RAPT Therapeutics Inc. (RAPT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    RAPT Therapeutics Inc.

    NASDAQ: RAPT · Real-Time Price · USD
    30.14
    1.04 (3.57%)
    At close: Oct 03, 2025, 3:59 PM
    29.50
    -2.12%
    After-hours: Oct 03, 2025, 07:26 PM EDT

    RAPT Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 169.74M 47.48M 38.95M 24.03M
    Short-Term Investments
    		 61.32M 111.38M 210.12M 165.63M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 389K 3.87M 4.04M 2.92M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 4.18M 2.92M 3.63M 3.32M
    Total Current Assets
    		 235.24M 161.78M 252.69M 192.97M
    Property-Plant & Equipment
    		 4.7M 7.68M 9.48M 2.74M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 5.09M 11.55M 13.52M 5.66M
    Total Assets
    		 240.32M 173.33M 266.21M 198.64M
    Account Payables
    		 1.27M 5.18M 3.37M 2M
    Deferred Revenue
    		 n/a n/a n/a 1.02M
    Short-Term Debt
    		 2.42M n/a 2.17M n/a
    Other Current Liabilities
    		 9.65M 7.91M 2.48M 2.93M
    Total Current Liabilities
    		 48.35M 21.84M 14.22M 9.6M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a 2.15M
    Total Long-Term Liabilities
    		 2.07M 4.46M 6.82M 2.66M
    Total Liabilities
    		 50.42M 26.29M 21.04M 12.26M
    Total Debt
    		 4.49M 6.91M 8.99M n/a
    Book Value
    		 189.9M 147.03M 245.17M 186.38M
    Book Value Per Share
    		 4.66 3.84 7.53 6.80
    Common Stock
    		 13K 3K 3K 3K
    Retained Earnings
    		 -614.55M -484.68M -367.88M -284.05M
    Comprehensive Income
    		 50K 103K -26K -206K
    Shareholders Equity
    		 189.9M 147.03M 245.17M 186.38M
    Total Investments
    		 61.32M 111.38M 210.12M 165.63M

    Add to Watchlist